{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:20:26Z","timestamp":1783524026214,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1007\/bf01259343","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T16:36:50Z","timestamp":1111595810000},"page":"35-43","source":"Crossref","is-referenced-by-count":5,"title":["d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment"],"prefix":"10.1007","volume":"64","author":[{"given":"D. P.","family":"van Kammen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","series-title":"Handbook of Psychopharmacology, Vol. II","first-page":"269","volume-title":"Stimulants: Neurochemical, Behavioral and Clinical Perspectives","author":"S. M. Antelman","year":"1983","unstructured":"Antelman, S. M., Chiodo, L. A.: Amphetamine as a Stressor. In: Stimulants: Neurochemical, Behavioral and Clinical Perspectives (Creese, I., ed.) (Handbook of Psychopharmacology, Vol. II), pp. 269?299, New York: Raven Press. 1983."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3181\/00379727-164-40878","volume":"164","author":"J. Blankestein","year":"1980","unstructured":"Blankestein, J., Reyes, F. I., Winter, J. S., Faiman, C.: Effects of naloxone upon prolactin and cortisol in normal women. Proc. Soc. Exp. Biol. Med.164, 363?365 (1980).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00426906","volume":"58","author":"W. A. Brown","year":"1978","unstructured":"Brown, W. A., Corriveau, D. P., Ebert, M. H.. Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacol.58, 189?195 (1978).","journal-title":"Psychopharmacol."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/joe.0.0400391","volume":"40","author":"P. W. P. Butler","year":"1967","unstructured":"Butler, P. W. P., Besser, G. M., Steinberg, H.: Changes in plasma cortisol induced by dexamphetamine and chlordiaxepoxide given alone and in combination in man. J. Endocr.40, 391?392 (1967).","journal-title":"J. Endocr."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0024-3205(81)90229-0","volume":"29","author":"M. R. Cohen","year":"1981","unstructured":"Cohen, M. R., Nurnberger, J. I., Pickar, D., Gershon, E., Bunney, W. E. jr.: Dextroamphetamine infusions in formais results in correlated increased of plasma beta-endorphine and cortisol immunoreactivity. Life Sci.29, 1243?1247 (1981).","journal-title":"Life Sci."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-1781(79)90027-1","volume":"1","author":"G. C. Davis","year":"1979","unstructured":"Davis, G. C., Buchsbaum, M., van Kammen, D. P., Bunney, W. E. jr.: Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone. Psychiat. Res.1, 45?52 (1979).","journal-title":"Psychiat. Res."},{"key":"CR7","unstructured":"DeFraites, E. G., Gold, P. W., Brown, G., van Kammen, D. P.: Urinary free cortisol in schizophrenia: Lack of effect of naltrexone (unpublished manuscript)."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(81)90230-7","volume":"29","author":"M. Dubois","year":"1981","unstructured":"Dubois, M., Pickar, D., Cohen, M. R., Roth, Y. F., MacNamara, T., Bunney, W. E. jr.: Surgical stress in humans is accompanied by an increase in plasma beta-endorphin immunoreactivity. Life Sci.29, 1249?1254 (1981).","journal-title":"Life Sci."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0024-3205(84)90091-2","volume":"34","author":"R. M. Eisenberg","year":"1984","unstructured":"Eisenberg, R. M.: Effects of naltrexone on plasma corticosterone in opiatenaive rats: A central action. Life Sci.34, 1185?1191 (1984).","journal-title":"Life Sci."},{"key":"CR10","unstructured":"Hommer, D. W., Davis, G., Linnoila, M., van Kammen, D.: Naltrexone treatment of schizophrenia, behavioral and biological effects (in preparation)."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0165-1781(81)90029-9","volume":"4","author":"L. L. Judd","year":"1981","unstructured":"Judd, L. L., Janowsky, D. S., Zettner, A., Leighton, Y. H., Takahashi, K. I.: Effects of naloxone-HCL on cortisol levels in patients with affective disorder and normal controls. Psychiat. Res.4, 277?283 (1981).","journal-title":"Psychiat. Res."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.6250217","volume":"209","author":"N. H. Kalin","year":"1980","unstructured":"Kalin, N. H., Risch, S. C., Cohen, R. M., Insel, T., Murphy, D. L.: Dexamethasone fails to suppress beta-endorphin plasma concentrations in humans and Rhesus monkeys. Science209, 827?828 (1980).","journal-title":"Science"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/0024-3205(77)90157-6","volume":"21","author":"D. T. Krieger","year":"1977","unstructured":"Krieger, D. T., Liotta, A., Li, C. H.: Human plasma immunoreactive betalipotropin: Correlation with basal and stimulated plasma ACTH concentrations. Life Sci.21, 1771?1778 (1977).","journal-title":"Life Sci."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1981.tb02746.x","volume":"15","author":"S. L. Lightman","year":"1981","unstructured":"Lightman, S. L.: Studies on the responses of plasma rennin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man. Clin. Endocrin.15, 45?52 (1981).","journal-title":"Clin. Endocrin."},{"key":"CR15","first-page":"459","volume":"97","author":"R. Marantz","year":"1976","unstructured":"Marantz, R., Sachar, E. J., Weitzman, E., Sassin, J.: Cortisol and GH responses to d- and l-amphetamine in monkeys. Endocrin.97, 459?465 (1976).","journal-title":"Endocrin."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-50-2-251","volume":"50","author":"J. E. Morley","year":"1980","unstructured":"Morley, J. E., Baranetsky, N. G., Wingert, T. D., Carlson, H. E., Hershman, J. M., Shlomo, M., Levin, S. R., Jamison, K. R., Weitzman, R., Chang, R. J., Varner,A. A.: Endocrine effects of naloxone-induced opiate receptor blockade. J. Clin. Endocrin. Metab.50, 251?257 (1980).","journal-title":"J. Clin. Endocrin. Metab."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00432677","volume":"74","author":"D. Naber","year":"1981","unstructured":"Naber, D., Pickar, D., Davis, G. C., Cohen, R. M., Jimerson, D. C., Elchisak, M. A., DeFraites, E. M., Kalin, N. H., Risch, S. C., Buchsbaum, M. S.: Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Psychopharm.74, 125?128 (1981).","journal-title":"Psychopharm."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0306-4530(81)90052-4","volume":"6","author":"C. M. Quirce","year":"1981","unstructured":"Quirce, C. M., Maickel, R. P.: Alterations of biochemical parameters by acute and repetitive stress situations in mice. Psychoneuroendocrin.6, 91?97 (1981).","journal-title":"Psychoneuroendocrin."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/228565a0","volume":"228","author":"L. Rees","year":"1970","unstructured":"Rees, L., Butler, P. W. P., Gosling, C., Besser, G. M.: Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine. Nature228, 565?566 (1970).","journal-title":"Nature"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.472735","volume":"205","author":"M. Ross","year":"1979","unstructured":"Ross, M., Berger, P. A., Goldstein, A.: Plasma beta-endorphine immunoreactivity in schizophrenia. Science205, 1163?1164 (1979).","journal-title":"Science"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpsyc.1981.01780350047005","volume":"38","author":"E. J. Sachar","year":"1981","unstructured":"Sachar, E. J., Halbreich, U., Asnis, G. M., Nathan, R. S., Holpern, F. S., Ostrow, L.: Paradoxical cortisol responses to dextroamphetamine in endogenous depression. Arch. Gen. Psychiat.38, 1113?1121 (1981).","journal-title":"Arch. Gen. Psychiat."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.1980.01780200033003","volume":"57","author":"E. J. Sachar","year":"1980","unstructured":"Sachar, E. J., Asnis, G., Nathan, R. S., Halbreich, U., Tabrizi, M. A., Halpern, F. S.: Dextroamphetamine and cortisol in depression: Morning plasma cortisol levels suppressed. Arch. Gen. Psychiat.57, 755?757 (1980).","journal-title":"Arch. Gen. Psychiat."},{"key":"CR23","first-page":"193","volume":"17","author":"S. C. Schulz","year":"1981","unstructured":"Schulz, S. C., van Kammen, D. P., Rogol, A. D., Ebert, M., Pickar, D., Cohen, M. R., Naber, D.: Amphetamine increases prolactin but neither growth hormone nor beta-endorphin immunoreactivity in schizophrenic patients. Psychopharm. Bull.17, 193?195 (1981).","journal-title":"Psychopharm. Bull."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-1781(92)90090-P","volume":"7","author":"S. C. Schulz","year":"1982","unstructured":"Schulz, S. C., van Kammen, D. P., Pickar, D., Cohen, M. R., Naber, D.: Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patients. Psychiat. Res.7, 171?178 (1982).","journal-title":"Psychiat. Res."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0024-3205(78)90130-3","volume":"23","author":"D. P. Kammen van","year":"1978","unstructured":"van Kammen, D. P., Docherty, J. P., Marder, S. R., Siris, S. G., Bunney, W. E. jr: Evaluations after chronic placebo, lithium and pimozide treatment. Life Sci.23, 1487?1492 (1978).","journal-title":"Life Sci."},{"key":"CR26","first-page":"991","volume":"8","author":"D. P. Kammen van","year":"1982","unstructured":"van Kammen, D. P., Bunney, W. E. jr., Docherty, J. P., Marder, S. R., Ebert, M. H., Rosenblatt, J. E., Rayner, J. N.: d-Amphetamine-induced heterogenous changes in psychotic behavior in schizophrenia. Am. J. Psychiat.8, 991?997 (1982).","journal-title":"Am. J. Psychiat."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/978-1-4684-4529-9_31","volume-title":"Psychoneuroendocrine Dysfunction in Psychiatric and Neurological Illness: Influence of Psychopharmacological Agents","author":"D. P. Kammen van","year":"1984","unstructured":"van Kammen, D. P., Schulz, S. C., Rogol, A. D.: Hormonal responses to d-amphetamine in schizophrenia. In: Psychoneuroendocrine Dysfunction in Psychiatric and Neurological Illness: Influence of Psychopharmacological Agents (Shah, N. S., Donald, A. G., eds.), pp. 549?567. New York: Plenum Press. 1984."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4684-3503-0_17","volume":"116","author":"J. Volavka","year":"1979","unstructured":"Volavka, J., Mallya, A., Bauman, J., Penvick, J., Cho, D., Reker, D., James, B., Dornbush, R.: Hormonal and other effects of naltrexone in normal men. Adv. Exp. Med. Biol.116, 291?305 (1979 a).","journal-title":"Adv. Exp. Med. Biol."},{"key":"CR29","first-page":"1056","volume":"300","author":"J. Volavka","year":"1979","unstructured":"Volavka, J., Cho, D., Mallya, A., Baumann, J.: Naloxone increases ACTH and cortisol levels in man. N. Eng. J. Med.300, 1056?1057 (1979 b).","journal-title":"N. Eng. J. Med."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0306-4530(80)90026-8","volume":"5","author":"J. Volavka","year":"1980","unstructured":"Volavka, J., Baumann, J., Pevnick, J., Reke, D., James, B., Cho, D.: Short term effects of naloxone in man. Psychoneuroendocrinology5, 225?234 (1980).","journal-title":"Psychoneuroendocrinology"},{"key":"CR31","first-page":"5","volume-title":"Progress and Prospects","author":"J. Zubin","year":"1980","unstructured":"Zubin, J.: The role of vulnerability in the etiology of schizophrenic episodes in treatment of schizophrenia. In: Progress and Prospects, pp. 5?33. New York: Grune and Stratton. 1980."}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01259343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01259343\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01259343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:03:47Z","timestamp":1556780627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01259343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["BF01259343"],"URL":"https:\/\/doi.org\/10.1007\/bf01259343","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}